Is there 1 impotence for every 5 men in China? Drug companies called unverifying accuracy


Is there 1 impotence for every 5 men in China? Drug companies called unverifying accuracy

Original title: 1 out of every 5 men in China are impotent? Changshan pharmaceutical industry issued a supplementary announcement that data accuracy is not verified

The Beijing News Bulletin (reporter Wang Cara) has 1 impotence among every 5 men in China. On the evening of May 15th, a bulletin issued by Changshan pharmaceutical company said that there were about 140 million Chinese men with erectile dysfunction (ED). This statement then triggered a hot debate. In May 16th, Changshan pharmaceutical industry reissued a supplementary announcement, saying that the data came from the relevant research report issued by Guoxin Securities in May 2014, which did not verify the accuracy of the data.

In the evening of May 15th, Changshan pharmaceutical industry announced that the wholly owned subsidiary of Changshan biochemical pharmaceutical industry (Jiangsu) Co., Ltd. recently received the citrate citrate tablet "drug GMP certificate" issued by the food and Drug Administration of Jiangsu province. Sildenafil citrate tablets, commonly known as Viagra, are mainly used to treat erectile dysfunction in men. According to the statistics of Changshan pharmaceutical industry, according to the statistics, the number of ED patients in China is about 140 million. If 30% of them are treated, the number will reach 42 million, and the potential market size in China is expected to reach 100 billion yuan in the future.

According to the data released by the National Bureau of statistics, the number of male population in China was 711 million 370 thousand in 2017. According to the Changshan pharmaceutical bulletin, 1 of every 5 men in China are erectile dysfunction patients. It is worth noting that, in 2016, the Guangsheng hall was issued a bulletin on Sildenafil Citrate Tablets's drug clinical trials approved by the State Administration of food and Drug Administration (SFDA), which referred to about 20 million erectile dysfunction patients in China. Changshan pharmaceutical bulletin mentioned "the number of domestic ED patients about 140 million people" data is true, authoritative hot debate.

In this regard, the Changshan pharmaceutical industry issued a supplementary announcement in May 16th that the data quoted in the May 15th announcement were mainly derived from the relevant research report issued by the state securities securities market at the end of May 2014. The company's securities department obtained and selected its description of the market space of sildenafil citrate through network retrieval. In addition, the company's securities department also inquired about the forecast of Soochow securities in February 28, 2017 about the market space of sildenafil citrate, referring to "the number of ED patients in China is about 127 million". As there is no other relevant market data, and the difference between the two reports is relatively small, the company's securities department reprinted the contents of Guoxin Securities.

The supplementary bulletin said, "for the prediction of the market space for sildenafil citrate, the company's securities department did not consult the report writer for its data sources and calculation methods, and did not verify the accuracy of the data. Ask the investors to pay attention to the risk of investment. " At the same time, the announcement also said, "the company has obtained the relevant approval documents needed to produce Sildenafil Citrate Tablets, but the market size, promotion progress and market share of the new product may be lower than expected, the future product sales situation has greater uncertainty, and there is also the risk of increasing competition in the product market." We invite the majority of investors to make prudent decisions and pay attention to investment risks.

Professor Bai Wenjun, a male expert in the Department of Urology, Peking University People's Hospital, was interviewed by the Beijing News reporter tonight. ED is not a disease, and it is a very subjective dysfunction. Unlike diabetes and hypertension, there is a very objective standard. The doctor often judges according to the patient's complaint. ED is also associated with mood, state, environment, age, health status and partners. Therefore, there is no large-scale, exact investigation and no clear data on the incidence of ED and the total number. "I don't know how the data (140 million people) were worked out, and I felt a little exaggerated."

Editor in responsibility: Zhang Yiling


Waonews is a news media from China, with hundreds of translations, rolling updates China News, hoping to get the likes of foreign netizens